- Home
- MED vs NKTX Comparison
MED vs NKTX Comparison
Compare MED & NKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MED
- NKTX
- Stock Information
- Founded
- MED 1980
- NKTX 2015
- Country
- MED United States
- NKTX United States
- Employees
- MED N/A
- NKTX N/A
- Industry
- MED Packaged Foods
- NKTX Biotechnology: Pharmaceutical Preparations
- Sector
- MED Consumer Staples
- NKTX Health Care
- Exchange
- MED Nasdaq
- NKTX Nasdaq
- Market Cap
- MED 156.7M
- NKTX 170.8M
- IPO Year
- MED N/A
- NKTX 2020
- Fundamental
- Price
- MED $13.09
- NKTX $1.85
- Analyst Decision
- MED Hold
- NKTX Strong Buy
- Analyst Count
- MED 1
- NKTX 6
- Target Price
- MED $16.50
- NKTX $15.00
- AVG Volume (30 Days)
- MED 199.3K
- NKTX 2.4M
- Earning Date
- MED 04-28-2025
- NKTX 03-26-2025
- Dividend Yield
- MED N/A
- NKTX N/A
- EPS Growth
- MED N/A
- NKTX N/A
- EPS
- MED 0.19
- NKTX N/A
- Revenue
- MED $602,463,000.00
- NKTX N/A
- Revenue This Year
- MED N/A
- NKTX N/A
- Revenue Next Year
- MED $2.10
- NKTX N/A
- P/E Ratio
- MED $68.53
- NKTX N/A
- Revenue Growth
- MED N/A
- NKTX N/A
- 52 Week Low
- MED $12.87
- NKTX $1.31
- 52 Week High
- MED $37.18
- NKTX $10.48
- Technical
- Relative Strength Index (RSI)
- MED 35.34
- NKTX 52.75
- Support Level
- MED $13.48
- NKTX $1.76
- Resistance Level
- MED $14.07
- NKTX $2.34
- Average True Range (ATR)
- MED 0.47
- NKTX 0.16
- MACD
- MED -0.05
- NKTX 0.06
- Stochastic Oscillator
- MED 11.96
- NKTX 51.94
About MED MEDIFAST INC
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. OPTAVIA provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. Medifast remains committed to its mission of offering Lifelong Transformation, Making a Healthy Lifestyle Second Nature.
About NKTX Nkarta Inc.
Nkarta Inc is a biopharmaceutical company engaged in developing engineered natural killer (NK) cells to treat cancer and autoimmune diseases. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer. The Company's operations are based in South San Francisco, California.